Neurotrophin‐3 reverses experimental cisplatin‐induced peripheral sensory neuropathy
暂无分享,去创建一个
H. Phillips | W. Gao | F. Hefti | N. Dybdal | J. Winslow | C. Schmelzer | N. Shinsky | W. Gao | Gilbert Keller | A. Murnane | C. Schmelzer | M. Siegel | G. Keller | J. Winslow | Wei-qiang Gao
[1] W. Snider,et al. Functions of the neurotrophins during nervous system development: What the knockouts are teaching us , 1994, Cell.
[2] S. McMahon,et al. Expression and coexpression of Trk receptors in subpopulations of adult primary sensory neurons projecting to identified peripheral targets , 1994, Neuron.
[3] Yves-Alain Barde,et al. Neurotrophin-3 enhances sprouting of corticospinal tract during development and after adult spinal cord lesion , 1994, Nature.
[4] M. Jacquin,et al. NGF Augmentation rescues trigeminal ganglion and principalis neurons, but not brainstem or cortical whisker patterns, after infraorbital nerve injury at birth , 1993, The Journal of comparative neurology.
[5] I. Silos-Santiago,et al. Neurotrophin receptor genes are expressed in distinct patterns in developing dorsal root ganglia , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[6] S. Korsching,et al. The neurotrophic factor concept: a reexamination , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[7] L. Cork,et al. Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease , 1993, Cell.
[8] E. Frank,et al. Neurotrophin 3 supports the survival of developing muscle sensory neurons in culture. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[9] Stephen R. Rapp,et al. Nerve Growth Factor Facilitates Regeneration across Nerve Gaps: Morphological and Behavioral Studies in Rat Sciatic Nerve , 1993, Experimental Neurology.
[10] F. Hefti,et al. Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[11] G. Wieneke,et al. Hypoxic neuropathy versus diabetic neuropathy An electrophysiological study in rats , 1992, Journal of the Neurological Sciences.
[12] S. Mühlhausen,et al. Changes in the cytoskeleton pattern of tumor cells by cisplatin in vitro. , 1992, Chemico-biological interactions.
[13] J. Arezzo,et al. Nerve growth factor prevents experimental cisplatin neuropathy , 1992, Annals of neurology.
[14] J. Arezzo,et al. Nerve growth factor prevents toxic neuropathy in mice , 1991, Annals of neurology.
[15] E. Roubos,et al. Morphological and electrophysiological study of the effects of cisplatin and ORG.2766 on rat spinal ganglion neurons. , 1990, Cancer research.
[16] J. Nagy,et al. Analysis of parvalbumin and calbindin D28k-immunoreactive neurons in dorsal root ganglia of rat in relation to their cytochrome oxidase and carbonic anhydrase content , 1989, Neuroscience.
[17] Mark J. Brown,et al. Dose‐dependent expression of neuronopathy after experimental pyridoxine intoxication , 1989, Neurology.
[18] A. Hart,et al. Monitoring of interaction products of cis-diamminedichloroplatinum(II) and cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) with DNA in cells from platinum-treated cancer patients. , 1988, Cancer research.
[19] W. Gispen,et al. Efficacy of the neuropeptide ORG.2766 in the prevention and treatment of cisplatin-induced neurotoxicity in rats. , 1988, European journal of cancer & clinical oncology.
[20] W. Gispen,et al. Evaluation of cis-diamminedichloroplatinum (II) (cisplatin) neurotoxicity in rats. , 1987, Toxicology and applied pharmacology.
[21] J W Griffin,et al. Neurofilament gene expression: a major determinant of axonal caliber. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[22] F. Hefti,et al. Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[23] P. Lohman,et al. Formation and repair of DNA interstrand cross-links in relation to cytotoxicity and unscheduled DNA synthesis induced in control and mutant human cells treated with cis-diamminedichloroplatinum(II). , 1985, Cancer research.
[24] D. Price,et al. Slow axonal transport in acrylamide neuropathy: different abnormalities produced by single-dose and continuous administration , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[25] L. Davis,et al. Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies , 1984, Cancer.
[26] A. Hirano,et al. Fine Structural Observations of Neurofilamentous Changes in Amyotrophic Lateral Sclerosis , 1984, Journal of neuropathology and experimental neurology.
[27] T. J. Walsh,et al. Neurotoxic effects of cisplatin therapy. , 1982, Archives of neurology.
[28] E. F. Stanley. Sensory and motor nerve conduction velocities and the latency of the H reflex during growth of the rat , 1981, Experimental Neurology.
[29] J. Whitehouse,et al. Cis-platinum: a new anticancer agent. , 1979, British medical journal.